Dr. Fedon Lindbergs Klinikk
Oslo, Norway
NCT Number: NCT01235208
The background for the trial is a number of previous studies indicating that it is especially important to restrict the intake of carbohydrates when treating overweight and metabolic diseases in general.
The purpose of the study is to obtain research data on the effects of an established treatment of overweight/obesity and its related metabolic disorders. The treatment, "Dr. Fedon Lindbergs Vektcoach", is a combination treatment where patients use low carbohydrate and low energy "Eurodiet" products in the initial phases. After the initial phases are completed, low glycemic normal foods are added to the diet until a sustainable and healthy diet is achieved. The treatment is of 7 month duration.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oslo, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diet and lifestyle treatment
Time frame: 7 months
Time frame: 7 months
Eurodiet Scandinavia AS
Industry
The Effect of a Low Carbohydrate Low Energy Ketogenic Diet Followed by Progressively Increased Intake of Low Glycemic Foods Over 7 Months on Weight and Body Composition and Hormonal Profile
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07065955
Autoimmune Diseases, Body Weight
Milan, Italy
View Trial DetailsNCT05120661
Body Weight, Digestion
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT04110717
Body Weight, Glucose Metabolism Disorders
Dublin, Ireland
View Trial DetailsNCT03520556
Body Weight, Cardiovascular Diseases
Québec, Canada
View Trial Details